These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


105 related items for PubMed ID: 1465916

  • 1. Impact of recipient and donor age on the outcome of renal transplantation.
    Rosman J, Steinhäuslin F, David S, Genton A, Mosimann F, Wauters JP.
    Transplant Proc; 1992 Dec; 24(6):2723-4. PubMed ID: 1465916
    [No Abstract] [Full Text] [Related]

  • 2. Comparison between donor-specific transfusions with conventional immunosuppression and triple therapy including cyclosporine in living related donor kidney transplantation.
    Arbelaez M, Mejia G, Henao JE, Garcia A, Arango JL, Velasquez A, Restrepo J, Garcia LF.
    Transplant Proc; 1992 Dec; 24(6):3096-7. PubMed ID: 1466072
    [No Abstract] [Full Text] [Related]

  • 3. Impact of donor age on graft function in living-related kidney transplantation.
    Längle F, Sautner T, Grünberger T, Götzinger P, Schuster G, Pohanka E, Steininger R, Mühlbacher F.
    Transplant Proc; 1992 Dec; 24(6):2725-7. PubMed ID: 1465917
    [No Abstract] [Full Text] [Related]

  • 4. Azathioprine can be safely stopped in triple drug induction protocols including cyclosporine and steroids in renal transplantation.
    Pallardó LM, Sánchez J, Sánchez P, García J, Orero E, Beneyto I, Ros F.
    Transplant Proc; 1992 Dec; 24(6):2604-5. PubMed ID: 1465880
    [No Abstract] [Full Text] [Related]

  • 5. Elective cyclosporine withdrawal in renal transplant recipients maintained on triple therapy.
    Keitel E, Bittar AE, Losekann A, Deboni L, Ceretta F, Goldani JC, Garcia VD.
    Transplant Proc; 1992 Dec; 24(6):2606-8. PubMed ID: 1465881
    [No Abstract] [Full Text] [Related]

  • 6. Analysis of risk factors affecting the outcome of primary living donor renal transplantation in Korea.
    Park K, Kim YS, Kim SI.
    Transplant Proc; 1992 Dec; 24(6):2426-7. PubMed ID: 1465816
    [No Abstract] [Full Text] [Related]

  • 7. Effect of recipient and donor relationship and sex on graft survival in living related renal transplantation. The Chilean Renal Transplantation Centers.
    Elgueta S, Fuentes C, Santamaría L, Wegmann ME, Meléndez M.
    Transplant Proc; 1992 Dec; 24(6):3074-5. PubMed ID: 1466061
    [No Abstract] [Full Text] [Related]

  • 8. Effect of donor-specific blood transfusions on graft outcome in live donor renal transplantations.
    Velidedeoğlu E, Tokyay R, Haberal M.
    Transplant Proc; 1992 Dec; 24(6):2752-3. PubMed ID: 1465927
    [No Abstract] [Full Text] [Related]

  • 9. Cardiovascular risk impact of cyclosporine immunosuppression in renal transplant recipients.
    Paul LC, Sutherland F, Klassen J, Buckle S, Burgess E.
    Transplant Proc; 1992 Dec; 24(6):2740-1. PubMed ID: 1465922
    [No Abstract] [Full Text] [Related]

  • 10. Late graft loss in cadaveric renal transplantation.
    Bergmann L, Roper L, Bow LM, Hull D, Bartus SA, Schweizer RT.
    Transplant Proc; 1992 Dec; 24(6):2718-9. PubMed ID: 1465913
    [No Abstract] [Full Text] [Related]

  • 11. Importance of certain HLA-A,B haplotypes for the survival of renal grafts from living-related donors.
    Polymenidis Z, Adam K, Parapanissiou E, Sakellariou G, Papakyriazi E, Antoniadis A, Papadimitriou M.
    Transplant Proc; 1992 Dec; 24(6):2458-60. PubMed ID: 1465830
    [No Abstract] [Full Text] [Related]

  • 12. Repeated HLA mismatch in multiple kidney transplantation: preliminary results of 146 retransplantations in the cyclosporine era.
    Gnant MF, Sautner T, Rosenmayr A, Muehlbacher F.
    Transplant Proc; 1992 Dec; 24(6):2466-8. PubMed ID: 1465833
    [No Abstract] [Full Text] [Related]

  • 13. Kidney transplantation in children with end-stage renal disease caused by urologic abnormalities.
    Kaliciński P, Kaminski A, Prokurat A, Prokurat S, Smirska E, Szymkiewicz C, Kaminski W.
    Transplant Proc; 1992 Dec; 24(6):2760-1. PubMed ID: 1465931
    [No Abstract] [Full Text] [Related]

  • 14. Renal transplantation without previous blood transfusions.
    Garcia VD, Goldani JC, Bittar AE, Keitel E, Bruno RM, Deboni L, Becker M, Messias AA, Losekann A, Bender D.
    Transplant Proc; 1992 Dec; 24(6):3094-5. PubMed ID: 1466071
    [No Abstract] [Full Text] [Related]

  • 15. Immunosuppression in live-related donor renal transplantation.
    Iman A, Rao M, Juneja R, Jacob CK.
    Natl Med J India; 2001 Dec; 14(2):75-80. PubMed ID: 11396322
    [Abstract] [Full Text] [Related]

  • 16. [Prognostic factors in the course of kidney transplantation].
    Opelz G.
    Urologe A; 1994 Sep; 33(5):377-82. PubMed ID: 7974925
    [Abstract] [Full Text] [Related]

  • 17. Living-unrelated renal transplantation.
    Simforoosh N, Bassiri A, Amiransari B, Gol S.
    Transplant Proc; 1992 Dec; 24(6):2421-2. PubMed ID: 1465814
    [No Abstract] [Full Text] [Related]

  • 18. Results of kidney transplantation from living unrelated donors.
    al Asfari R, Hadidy S, Yagan S.
    Transplant Proc; 1995 Oct; 27(5):2591. PubMed ID: 7482842
    [No Abstract] [Full Text] [Related]

  • 19. Renal transplantation in the elderly: surgical complications and outcome with special emphasis on the Eurotransplant Senior Programme.
    Bentas W, Jones J, Karaoguz A, Tilp U, Probst M, Scheuermann E, Hauser IA, Jonas D, Gossmann J.
    Nephrol Dial Transplant; 2008 Jun; 23(6):2043-51. PubMed ID: 18203840
    [Abstract] [Full Text] [Related]

  • 20. Autoreactive IgM non-HLA antibodies are not entirely clinically irrelevant. The Manchester UK Kidney Transplant Team.
    Martin S, Dyer PA, Scott PD.
    Transplant Proc; 1992 Dec; 24(6):2504. PubMed ID: 1465846
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.